Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

GAMOMAT Grows its Gaming for the Climate Initiative with Alexandria Fire Collaboration with WeForest

GAMOMAT, one of the leading independent software developers for slot games, has grown its Gaming for the Climate initiative by adding Alexandria Fire to further its mission of climate action.Gaming for the Climate is a passion project that launched in 2021 to support global initiatives combating the climate crisis. Alexandria Fire becomes the fourth of GAMOMAT’s titles to join the initiative and will be aligned with the renowned non-profit organisation, WeForest. As a core driver of the Gaming for the Climate programme, a portion of the revenue from Alexandria Fire will be donated to

New Consulting Firm ‘Axcelture’ launched - Focus on ‘Essential Products and Services’

Jesper K. Pedersen, CEO and founder of Axcelture, sees an opportunity to back medium to large enterprises with consulting- and project services, and supporting other consulting firms with project consulting and advisory.Press Release November 6, 2024   Jesper K. Pedersen, who worked at Pandora as head of security, and global loss prevention and compliance, launched Axcelture this year to lean heavily into consulting. Pedersen, has 20+ years of experience in the security and risk management industry globally. He (Jesper K. Pedersen) have worked in various capacities for some of the

Salsa to Showcase its LatAm Gateway Credentials at SiGMA Europe

Salsa Technology will attend SiGMA Europe, taking place from 12th to 14th November in Valletta, Malta, with the aim of establishing and strengthening partnerships with game providers expanding into the Latin American market. Representing the company at the event will be Head of Marketing & Sales, Eliane Nunes, and Operations & Support Manager, Cathiussa Canez.Salsa Technology’s content aggregator, Salsa Gator, has positioned itself as a strategic bridge for providers seeking to replicate their success from other regulated markets in Brazil and other LatAm countries, such as Peru. With a

Vermiculus opens new office in Umeå to support continued growth

New location in one of the strongest fintech hubs in the Nordics strengthens Vermiculus’ capacity to meet global demand.Umeå, November 6, 2024, Vermiculus, a global provider of trading, clearing, and CSD technology, is growing rapidly and is pleased to announce the opening of its new office in the university town Umeå, in Northern Sweden. “We are so excited to welcome our first colleagues to the Umeå office and this marks another new milestone for Vermiculus. I am looking forward to the journey ahead with our growing team in Umeå and to work so closely with many brilliant minds,” said

BioStock: Biosergen’s CEO: “I’m optimistic that we may cure patients”

Biosergen recently announced the completion of treatment for the first cohort of patients in its proof-of-concept trial for its antifungal drug candidate BSG005. Most patients improved significantly, reflecting BSG005’s potential as a life-saving therapy. The next step involves dose escalation for the upcoming cohort. Importantly, between November 18 and 29, shareholders can exercise the warrants TO3, which could add a maximum of approximately SEK 45 million to the company, funding it well through 2025.Read the interview with CEO Tine Olesen at biostock.se: https://www.biostock.se/en/

Heimdal and COOLSPIRiT Team Up to Strengthen UK Business Cybersecurity

LONDON, United Kingdom, 6th November 2024 – Heimdal, a leading provider of advanced cybersecurity solutions, and COOLSPIRiT, a UK-based expert in data management and IT infrastructure, are pleased to announce a strategic partnership to deliver cutting-edge security technologies to businesses across the UK.Today’s organizations face sophisticated cyber threats targeting critical systems and data. Recognizing this challenge, COOLSPIRiT sought a cybersecurity partner whose advanced security technologies align with their mission to provide clients with best-in-class solutions. "We are

Gedea´s share issue oversubscribed by 54%

Gedea Biotech AB carried out a rights issue of SEK 24.3 million during October. The interest from both existing owners and new investors exceeded the board’s mandate, and an extraordinary general meeting resolved a directed issue to include the oversubscription of SEK 13 million. In total, Gedea has after issue costs received SEK 34.8 million.Earlier this year, Gedea received a €2.5 million grant from the Horizon 2020 EIC program, which provided a EU quality stamp to our program efforts. Strengthened by this EU support, the company is now finalizing the CE marking process according to the

Riku Lyly appointed Chief Operating Officer (COO) of Lindex Group plc's Stockmann division and member of the Group Management Team

LINDEX GROUP plc, Changes board/management/auditors, 6.11.2024, at 12:00 EET Riku Lyly appointed Chief Operating Officer (COO) of Lindex Group plc's Stockmann division and member of the Group Management TeamRiku Lyly, b.1984 (M.Sc.) has been appointed Chief Operating Officer (COO) of the Lindex Group plc’s Stockmann division and member of the Lindex Group Management Team as of 6 November 2024. Riku Lyly has worked as Stockmann division’s interim Chief Operating Officer (COO) from 15 August 2024. Prior to this, he held the position of Chief Offering and Experience Officer of the

Form 8.3 - Anglogold Ashanti Plc

FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   +--------------------------------------------------------+---------------------+|(a) Full name of discloser: |Ninety One UK Ltd |+--------------------------------------------------------+---------------------+|(b) Owner or controller of interests and short positions|  ||disclosed, if different from 1(a):

New board member of CLS buys shares in the company and the CEO and EVP Operations increase their shareholdings

Lund, Sweden – Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today announces that the Company's new Board member Peter Mantas, the CEO, Dan J. Mogren, and EVP Operations, Jimmy Johansson, have purchased a total of 22,000 Class B shares in CLS.Peter Mantas acquired 10,000 shares bringing his total holding to 10,000 Class B shares on Wednesday, November 6th. Dan J. Mogren completed the purchase of 8,000 shares on November 5th. After the transactions, Dan J. Mogren's total holding amounts to 30,939 Class B shares plus 632 Class B shares via Medinovus AB. Jimmy

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 239 – 6 NOVEMBER 2024   In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 235/24 and 237/24.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Therese Möllevinge, Head of Investor Relations, tel.: +45 41 37 16 38, e-mail: thm@norden.com Isabella Zaugg Hansen, Investor Relations Manager, tel.: +45 27 62 90 96, e-mail: izh@norden.com

SAS achieves landmark IATA IEnvA assessment certification

SAS has received official approval of its IEnvA Assessment Report, marking a significant milestone in the company’s commitment to environmental sustainability.As the aviation industry faces growing concerns regarding its environmental footprint, SAS leads in sustainable practices, continuously updating its Environmental Management System to align with industry standards. This achievement not only highlights SAS leadership in environmental stewardship but also serves as a model for others in the industry.  “SAS is the first airline within the SkyTeam alliance to receive the IATA IEnvA

CasinoRank Unveils Comprehensive Analysis of the Best Crash Games with Demo Play

Stockholm, Sweden, November 2024 – MobileCasinoRank, a leading platform in mobile casino content and reviews is excited to present its latest analysis of the best crash games of 2024, now with a new Demo Play option available on its website. This feature allows users to try popular crash games for free, providing an opportunity to experience these high-risk, high-reward games without wagering real money. The report offers valuable insights into top titles captivating mobile casino players, such as Aviator by Spribe, Spaceman by Pragmatic Play, Big Bass Crash, Astronaut, and Cash Or Crash Live.

Gentoo Media: Invitation to Q3 2024 results presentation

Gentoo Media Inc. publishes its interim report for the third quarter 2024 before market opening on Wednesday 13 November 2024. Jonas Warrer, CEO, will host a presentation of the Q3 2024 results via livestream at 09:00 CET. The presentation will be followed by a Q&A-session, and investors, analysts and journalists are welcome to participate. The presentation will be given in English. Link to the livestream:https://www.redeye.se/events/1045411/live-q-gentoo-media For further information, please contact:Tore Formo, Group CFO, tore.formo@g2m.com, +47 91668678 About Gentoo Media

Navamedic launches Eroxon[®] in Finland

Oslo, 6 November 2024 – Building on the successful product launch of Eroxon[®] in Norway and Sweden earlier this year, Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, is now launching Eroxon[®] across pharmacies in Finland. Eroxon[®] will be the first clinically proven over-the-counter topical treatment for the treatment of erectile dysfunction in men in Finland.Eroxon[®] is part of Navamedic’s increasingly growing Consumer Health category. Since the product launched in Norway in February 2024, Eroxon[®] has

AddSecure officially launches alarm signalling services in the UK

Focused on ensuring the seamless continuity of the Next Generation Portfolio, AddSecure provides uninterrupted service to its customersAddSecure , a leading European provider of secure IoT connectivity and end-to-end solutions with a special focus on alarm signalling solutions, today announced the official launch of its operations in the UK market. This launch marks a significant milestone for AddSecure as it continues to expand its presence and offerings in the industry.   As part of this launch, AddSecure is introducing the Next Generation Portfolio (

Read original

NIB in Q1-Q3: Stable financial results with high increase in new signed lending

During the first nine months of 2024, the Nordic Investment Bank (NIB) delivered net profit of EUR 198 million (EUR 195 million in the same period in 2023) and disbursed EUR 2.4 billion (EUR 2.0 billion). NIB’s new signed lending increased to EUR 3.2 billion compared to EUR 1.6 billion the same period last year.During the third quarter, new lending was distributed across various sectors and countries and will finance investments in energy sector, digital transformation, and research and development, for example.“Our financial performance and high level of activity indicates a good

The exercise period for subscription of shares through exercise of warrants of series TO5 begins today

NOT FOR RELEASE, PUBLICATION, OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, JAPAN, NEW ZEALAND, RUSSIA, SOUTH AFRICA, SOUTH KOREA, CANADA, OR IN ANY OTHER JURISDICTION WHERE DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR REQUIRE FURTHER ACTIONS BEYOND THOSE REQUIRED BY SWEDISH LAW. Today, 6 November 2024, the exercise period for warrants of series TO5 (“TO5”) in PEPTONIC medical AB ("Peptonic" or “the Company”) begins. The exercise period runs from and including November 6, 2024, until and including November 20, 2024. Each TO5 entitles

In-depth analysis showing robust Diamyd[®] treatment effects across clinical trials to be shared at the 2024 IDS Diabetes Congress

(IDS) Congress in Bruges, Belgium. The analysis will be presented at a Satellite Symposium organized by Abbott. The results support the robustness of the treatment effects and underscore the potential for precision medicine to slow and delay disease progression in Type 1 Diabetes.”These analyses clarify the robustness of our previous treatment results across trials in our genetically defined responder patient group, and further characterize the effect of Diamyd[®] on glycemic control”, says Ulf Hannelius, CEO of Diamyd Medical. “These insights together with the benign safety profile are

PHI's new CEO to BioStock: "I am excited to lead us forward with new energy"

Anders Månsson was recently appointed CEO of Phase Holographic Imaging. With extensive leadership experience in the international life sciences sector, he aims to expand PHI’s global reach and position the company as a leader in non-invasive cell quality control technologies. We spoke with him about his vision for the future.Read the full interview with Anders Månsson at biostock.se: https://www.biostock.se/en/2024/11/phis-new-ceo-i-am-excited-to-lead-us-forward-with-new-energy/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

Announcement of a Change in Shareholding According to Chapter 9, Section 10 of the Finnish Securities Market Act

Sitowise Group Plc Stock Exchange Release 6 November 2024 at 9.45 a.m. (EET) Sitowise Group Plc (the "Company") has on 5 November 2024 received a notification in accordance with the Chapter 9, Section 10 of the Finnish Securities Market Act from Morgan Stanley, according to which Morgan Stanley & Co International Plc's holding of the shares and votes of the Company has increased above 5.00 percent on 4 November 2024. According to the notification, Morgan Stanley holds indirectly a total of 46,560 shares corresponding to 0.13 percent of the Company’s shares and votes, and a total of 2,

Renowned international expert in medicine Dr. Charles Alessi joins Nightingale Health UK as Chief Medical Officer

Nightingale Health Plc Press release 6 November 2024 at 09:45 a.m. (EET)   Nightingale Health, a pioneer in disease risk detection and preventative health has appointed internationally recognised expert in medicine Dr. Charles Alessi as Chief Medical Officer of Nightingale Health UK.   Dr. Charles Alessi is a physician with more than 35 years of experience in all aspects of policy and clinical practice in the United Kingdom, Northern Ireland and globally. Alessi’s experience includes key positions in some of the world leading organisations in the industry, such as acting

NYAB AB’s Interim Report January-September 2024: Doubled order backlog and strong profit improvement

· Solid revenue growth and strong project execution · Improved operating margins and net profit · Favorable market conditions resulting in a record-high order backlog July-September in brief · Revenue amounted to EUR 93.6 (88.1) million, representing a change of 6.2%. In constant currencies, revenue growth was 4.2%. · Operating profit (EBIT) improved 35.4% and was EUR 8.9 (6.6) million, amounting to 9.5% (7.5%) of revenue. · Free cash flow was EUR -8.3 (-3.8) million. · Net debt/EBITDA was 0.06 (0.30). · Order backlog improved 108.4% and amounted to EUR 381.9 (183.

There are no items matching the current filter
There are no more items matching the current filter
Back to top